What is lung cancer screening?
Lung cancer screening is an essential medical test designed to detect lung cancer in its early stages, even before symptoms appear. It is recommended primarily for those at high risk—especially older people who have a long history of smoking. Lung cancer often develops silently. It does not cause noticeable signs or symptoms until it is in advanced stages. When symptoms do occur, treatment becomes more challenging, and the chances of successful recovery are reduced. Early detection of lung cancer screening will increase the chance of a more effective treatment.
Who should be screened for lung cancer?
Generally, Lung cancer screening is recommended for people at high risk for the disease. This is especially true for adults ages 55 to 80 who have smoked for many years. The screening process is simple, non-invasive and can help catch cancer in its early and highly treatable stages. Screening is generally not recommended for younger individuals or those without a significant smoking history. This is because the risk of lung cancer is much lower in these populations. However, for those at high risk, regular screening is an essential step in protecting their health.
The screening test used to detect lung cancer is called low-dose computed tomography (LDCT). This imaging technique allows healthcare providers to create detailed images of the lungs using a dose of radiation. Much more detailed than traditional CT scans, LDCT can reveal small lumps or abnormalities in the lungs that may indicate early-stage lung cancer. This makes it a highly effective tool for early diagnosis of disease.
Participation in Om Research in Lung Cancer Screening
Om Research is at the forefront of efforts to improve methods for early detection of lung cancer. In addition to routine lung cancer screening, Om Research is leading a clinical study that aims to advance our understanding of lung cancer detection by looking at specific markers in the blood. The goal of this study was to develop new methods. that can help detect lung cancer faster and more accurately.
Patients who choose to participate in the study will be required to undergo standard lung cancer screening. Lung Cancer Screening includes a low-dose CT scan. This scan provides detailed images of the lungs and helps detect small lumps or suspicious areas. By combining data from LDCT scans with information gathered from blood markers, this study is aiming towards a future where lung cancer screening can detect lung cancer more reliably. It increases the chances of successful treatment and patient survival.
The LDCT scan used in the study is a groundbreaking tool for the early detection of lung cancer. It is a safe option for long-term monitoring of high-risk patients due to reduced radiation exposure. The ability to detect lung cancer early means that patients have more treatment options and a better chance of recovery. Om Research ensures every patient receives the most up-to-date and effective care possible.
Impact of early detection on lung cancer survival
We should not underestimate the importance of early detection of lung cancer. When lung cancer occurs in its early stages, The chance of recovery is much higher. Early diagnosis will provide more treatment options and a greater chance of success. Low-dose CT scans have revolutionized the early detection of lung cancer by reducing radiation exposure and providing highly detailed images. This technology is especially effective in identifying small, potentially cancerous lumps not visible on standard X-rays. For people at high risk, Regular LDCT screening is essential to identify lung cancer at a stage when lung cancer can still be successfully treated.
Our clinical trials at Om Research aim to take this further by combining LDCT testing with advanced blood marker analysis and looking for specific biological markers associated with lung cancer. We strive to identify this disease before it even appears on imaging tests. This innovative approach can lead to earlier diagnosis and better outcomes for patients.
A step towards a healthier future
Lung cancer screening is an essential tool in the fight against one of the world’s deadliest cancers. Early detection Methods such as low-dose CT scans can significantly alter clinical outcomes. Lung Cancer Screening gives patients a better chance of survival. At Om Research, we are proud to be part of this effort through our ongoing research and clinical trials.
By combining cutting-edge research in blood markers with advanced imaging techniques, the study is aiming to improve the accuracy and effectiveness of lung cancer screening. Our mission is to provide the best patient care possible and to advance medical science for the benefit of all. Lung cancer screening for people at high risk is more than just screening. It is the path to better health and a longer life.
Om Research is Enrolling Clinical Trials at site locations mentioned below :
Lung Cancer Screening in Oxnard: https://omclinicaltrials.com/clinical-study/#!/study/107/apply
